NEW
Font size
WorksheetsHealth Education 10 (First Quarter Quiz)
Total questions: 10
Worksheet time: 13mins
1. Which of the following statements are TRUE when it comes to identifying Covid-19 Variants?
I. Variants are particular versions of the virus that has a specific combination of mutations across its genomes.
II. A variant becomes a variant of concern if it seems to be spreading even faster over a period of time.
III. Mutations are changes that occur in the genome of the virus as it makes copies and moves from one person to another.
IV. New variants are not that transmissible and will not cause an increase in terms of the severity of the disease.
A. I, III, and IV
B. I and III only
C. II and IV only
D. I, II, and III
2. Which of the following is TRUE about Hydroxychloroquine as a treatment for Covid-19?
A. According to World Health Organization, after having six clinical trials, Hydroxychloroquine can be used as a treatment in decreasing the likelihood the death or speeding recovery.
B. According to World Health Organization, after having six clinical trials, Hydroxychloroquine can partially be used for about 10% as a treatment for decreasing the likelihood the death or speeding recovery.
C. According to World Health Organization, after having six clinical trials, Hydroxychloroquine has no benefit in decreasing the likelihood the death or speeding recovery.
D. According to World Health Organization, after having six clinical trials, Hydroxychloroquine can partially be used for about 50% as a treatment for decreasing the likelihood the death or speeding recovery.
3. If a vaccine is showing a “95% efficacy” rate, does that mean you would still get infected with Covid-19?
A. No. Because you are 100% protected by the vaccine and are sure to not have Covid-19 anymore.
B. Yes, but the risk of coming down to Covid-19 is 95% reduced compared to an unvaccinated person.
C. Yes, but the risk of coming down to Covid-19 is 5% reduced compared to an unvaccinated person.
D. Yes, because the vaccines were created very quickly that the efficacy rates, even if it’s 95%, are not that reliable.
4. Which of the following statements are TRUE about how Covid-19 is being transmitted between people?
I. The virus can spread when aerosols/droplets containing the virus are inhaled.
II. The virus can also spread in poorly ventilated and/or crowded indoor settings, where people tend to spend longer periods of time.
III. The virus can easily spread if you are wearing a medical mask and you avoid prolonged contact with other people.
IV. The virus spreads mainly between people who are in close contact with each other, typically within six feet.
A. I, and IV only
B. I, II, and IV
C. II, III, and IV
D. II and III only
5. Acute Respiratory Distress Syndrome is one of the fatal comorbidities of Covid-19 and it occurs when ________.
A. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream and deprives your organs of the oxygen they need to function properly.
B. Your airways narrow and swell and may produce extra mucus. This can make breathing difficult and trigger coughing, a whistling sound (wheezing) when you breathe out, and shortness of breath.
C. The main airways of the lungs are infected, causing them to become irritated and inflamed. The main symptom is a cough, which may bring up yellow-grey mucus (phlegm).
D. The walls between many of the air sacs in the lungs are damaged. This causes the air sacs to lose their shape and become floppy. The damage also can destroy the walls of the air sacs, leading to fewer and larger air sacs instead of many tiny ones. This makes it harder for your lungs to move oxygen in and carbon dioxide out of your body.
6. This variant was first reported in Japan but later identified as originating in Brazil, which may be able to re-infect people who have had COVID-19.
A. Alpha (B.1.1.7)
B. Beta (B.1.351)
C. Delta (B.1.617.2)
D. Gamma (P.1)
7. This variant first reported in South Africa spreads more easily. Some current treatments and vaccines may not work as well in cases of this variant.
A. Alpha (B.1.1.7)
B. Beta (B.1.351)
C. Delta (B.1.617.2)
D. Gamma (P.1)
8. This variant first reported in the UK spreads more easily and can cause more severe illness.
A. Alpha (B.1.1.7)
B. Beta (B.1.351)
C. Delta (B.1.617.2)
D. Gamma (P.1)
9. A COVID-19 vaccine with 66.4% efficacy against symptomatic patients and has (1) one dose.
A. Moderna
B. Sinopharm
C. Oxford - Astrazeneca
D. Johnson and Johnson’s
10. A COVID-19 vaccine with 95-100% efficacy against symptomatic patients and has (2) doses, 21 days apart.
A. Sinovac (Coronavac)
B. Pfizer (BioNTech)
C. Oxford - Astrazeneca
D. Johnson and Johnson’s
